Full text is available at the source.
The body’s internal clock protein helps increase artery-damaging enzymes in acrolein-linked artery disease, involving changes in gut bacteria
Updated
Abstract
Patients with atherosclerosis exhibited higher levels of MMP9 and lower expression of Clock and Bmal1.
- MMP9 is identified as a promising biomarker for atherosclerosis.
- Acrolein exposure increased MMP9 and decreased the expression of Clock and Bmal1 in human umbilical vein endothelial cells.
- Knockdown of Clock or Bmal1 resulted in upregulation of MMP9 in endothelial cells.
- Atherosclerotic mice exposed to acrolein showed similar changes in MMP9, Clock, and Bmal1 levels.
- Acrolein exposure altered gut microbiota composition, specifically increasing Firmicutes and decreasing Bacteroidetes.
- Gut microbiota changes correlated with levels of atherosclerotic plaque, MMP9, and Bmal1.
Simplified